Get started
Author

Takehiro Taninaga

Observed names: T. Taninaga, Taninaga, Takehiro
Institution: Eisai (Japan)
Observed institution: Eisai (Japan)
OpenAlex ID: A5041148844
Orexin receptor antagonists in the treatment of insomnia associated with psychiatric disorders: a systematic review
2024 · Taro Kishi, Michinori Koebis, et al. · Translational Psychiatry · 37
PDF
Evidence‐based insomnia treatment strategy using novel orexin antagonists: A review
2021 · Taro Kishi, Maika Nishida, et al. · Neuropsychopharmacology Reports · 31
Efficacy and Safety of Transitioning to Lemborexant from Z-drug, Suvorexant, and Ramelteon in Japanese Insomnia Patients: An Open-label, Multicenter Study
2024 · Motohiro Ozone, Susumu Hirota, et al. · Advances in Therapy · 24
Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended-release for insomnia disorder subtypes defined based on polysomnographic findings
2022 · Yuichi Inoue, Maika Nishida, et al. · Journal of Clinical Sleep Medicine · 15
PDF
Reduced versus maximum tolerated methotrexate dose concomitant with adalimumab in patients with rheumatoid arthritis (MIRACLE): a randomised, open-label, non-inferiority trial
2023 · Hiroya Tamai, Kei Ikeda, et al. · The Lancet Rheumatology · 14
Evaluation of prescribing patterns of switching to and add-on lemborexant in patients treated with hypnotic medication: a nationwide claims database study in Japan
2024 · Sachiko Tanaka-Mizuno, Kenichi Fujimoto, et al. · Expert Opinion on Pharmacotherapy · 10
Op0128 Pharmacokinetics and Pharmacodynamics of Methotrexate Polyglutamate in Patients With Rheumatoid Arthritis Treated With Low or High Dose-methotrexate in Combination With Adalimumab: Results From the Miracle Trial
2023 · H. Tamai, K. Ikeda, et al. · Annals of the Rheumatic Diseases · 2
PDF
A multicenter, open-label study to evaluate the efficacy and safety of lemborexant alternative therapy in subjects with insomnia (Somnus study)
2024 · M. Ozone, S. Hirota, et al. · Sleep Medicine · 1
Ab0253 Comparison of Pharmacodynamics of Methotrexate as Methotrexate-polyglutamates Concentrations in Rheumatoid Arthritis; Interim Data Evaluation of Miracle Study Conducted in Japan, Korea and Taiwan
2021 · H. Tamai, Y. Kaneko, et al. · Annals of the Rheumatic Diseases · 1
Self-reported sleep variables, sleep quality, and quality of life assessment in transition to lemborexant in patients with Insomnia: the multicenter, open-label SOMNUS study
2025 · Motohiro Ozone, Susumu Hirota, et al. · Sleep Medicine X
48. Transitioning Between Drug Classes in Elderly Adults: Data From Two Studies With Lemborexant and Z-drugs
2025 · Motohiro Ozone, Maha Ahmad, et al. · American Journal of Geriatric Psychiatry
An Open-label, Multicenter Study to Evaluate the Efficacy and Safety of Treatment With Lemborexant in Subjects With Chronic Insomnia (somnus Study)
2025 · *Motohiro Ozone, Susumu Hirota, et al. · The International Journal of Neuropsychopharmacology
Transitioning Between Drug Classes: Data From Two Studies With Lemborexant and Z-drugs
2025 · Russell Rosenberg, *Motohiro Ozone, et al. · The International Journal of Neuropsychopharmacology
Transitioning Between Z-drugs and Lemborexant: Data from Two Studies (P8-9.016)
2024 · Russell Rosenberg, Motohiro Ozone, et al. · Neurology
Comparison of the treatment effectiveness between lemborexant and zolpidem tartrate extended release for insomnia disorder subtypes
2024 · Y. Inoue, M. Nishida, et al. · Sleep Medicine
Transitioning between drug classes: data from two studies with lemborexant and Z-drugs
2024 · R. Rosenberg, M. Ozone, et al. · Sleep Medicine
Transitioning from Z-drugs to lemborexant: impact on patient satisfaction with treatment
2024 · R. Rosenberg, M. Ozone, et al. · Sleep Medicine
Clinical efficacy and pharmacokinetics of Dayvigo (Lemborexant) on insomnia.
2020 · Michinori Koebisu, Sugawara Michiko, et al. · 臨床精神薬理
Works count: 19
Citation count: 135
H-index: 6
I10-index: 6
Year
Topic
Type